MedellinIVF.coMedellín IVFColombian IVFColombia MedicalCompare a quote
Independent fertility planning · Updated October 2026

PGT-A With IVF in Medellín: When the Add-On May or May Not Help

PGT-A is offered widely, but the evidence for it depends a great deal on who you are. Here is what ASRM and the HFEA say, group by group, and what the test changes about your trip.

Educational information for patients comparing fertility care in Medellín. Not medical advice.

Bottom line: PGT-A (preimplantation genetic testing for aneuploidy) checks embryos for an abnormal number of chromosomes. ASRM says its value as a routine test for all IVF patients has not been shown, and the UK regulator rates it red for improving the chance of a baby for most patients. It may be reasonable in some situations. Ask what decision the result would change for you.

What PGT-A does, and what it does not do

In PGT-A, a few cells are taken from each embryo, usually at the blastocyst stage, and sent to a genetics lab to count the chromosomes. Embryos reported as having the expected number are prioritised for transfer.

The key point is that PGT-A selects. It does not improve an embryo or create more of them. The UK regulator’s PGT-A rating page (HFEA, 2023) describes it as a selection tool that often reduces the number of embryos available for transfer. It says PGT-A may shorten the time to pregnancy for some patients but may lengthen it for most. The HFEA lists no known additional risk to the person having treatment. The risks it lists fall on the embryos and on the decisions made from the results.

What the evidence says overall

ASRM’s 2024 committee opinion on PGT-A says its value as a universal screening test for everyone having IVF has not been demonstrated. It concludes that routine biopsy and aneuploidy testing for all infertility patients cannot be recommended. It notes that recent multicentre randomised trials, in women who had blastocysts available, found overall outcomes similar with or without PGT-A. In the STAR trial it reviews, the ongoing pregnancy rate per intention to treat was 41.8% with PGT-A and 43.5% without.

The HFEA’s ratings run in the same direction:

On value for money, ASRM says the cost-effectiveness of PGT-A is difficult to quantify because cycle prices and insurance coverage vary so much. The models it reviews give mixed results. One found PGT-A not cost-effective in unexplained recurrent pregnancy loss, while another found it shortened treatment by about four months. ASRM’s conclusion is that the decision needs individual counselling rather than a blanket rule.

Situation by situation

Whether PGT-A is worth discussing depends heavily on your circumstances. This table summarises what the 2024 ASRM opinion says for common groups, plus ASRM’s 2026 opinion on repeated failed transfers.

Your situationWhat ASRM saysQuestion to ask the clinic
Any IVF patient, as a routine testRoutine use for all patients cannot be recommendedWhy are you offering this to me specifically?
Older patient using own eggs, with good ovarian reservePGT-A may have a beneficial role, but the evidence comes from small or observational studiesHow many blastocysts do you expect me to have to test?
Using donor eggsThe overall evidence argues against routine useWhat reason applies in my case?
Older male partnerRoutine PGT-A should not be done for this reasonIs there another indication?
Male-factor infertilityShould not be used for this reason aloneWhat would the result change?
Recurrent pregnancy lossEvidence is observational, and definitive benefit is lackingHave the other causes of loss been evaluated?
Several failed transfersASRM’s 2026 opinion says it may be offered through shared decision-making, but there is no evidence it raises the chance of live birth in this groupWhat else is planned to investigate the failures?

If you are over 40 and weighing this, our guide to IVF over 40 in Medellín puts PGT-A alongside the other decisions you will face.

PGT-A is not the same as other embryo tests

Clinics sometimes use “genetic testing” loosely, so check which test is meant. PGT-A screens for an abnormal number of chromosomes. Other tests look for specific known problems. PGT-M is used when a parent carries a known single-gene condition, and PGT-SR is used when a parent has a structural chromosome rearrangement. ASRM’s 2026 opinion on repeated implantation failure, for example, says genetic counselling is recommended and PGT-SR may be offered when a parent’s karyotype shows a structural abnormality. Those are different conversations from routine aneuploidy screening. If you have a known family condition, raise it directly rather than assuming PGT-A will cover it.

The risks to understand before you consent

The HFEA lists these risks of PGT-A:

ASRM adds detail on two of these. On mosaicism, it says mosaic embryos may implant at lower rates but can result in apparently healthy babies, and that mosaic rates vary with the testing platform, the thresholds used and how the lab classifies results. On false results, it describes one retrospective analysis estimating that about 1 in 6 embryos with reproductive potential might have been discarded as mosaic or falsely abnormal. It also notes the authors’ caveat that their methods may have affected that figure. ASRM recommends counselling about mosaic results, misdiagnosis, the option of not testing, and what happens to embryos reported as abnormal.

What PGT-A changes about your Medellín trip

For an international patient, the practical effect is often bigger than the price of the test. Biopsied embryos are usually frozen while results come back. A fresh transfer on the retrieval trip then generally gives way to a frozen transfer on a later trip. Ask the clinic:

Our guide to freeze-all IVF in Medellín explains how a first trip can end without a transfer and how to plan the return.

When PGT-A may be worth discussing, and when it may not

It may be worth a careful conversation if you are older, are using your own eggs, have good ovarian reserve and expect several blastocysts. It may also be worth discussing if avoiding a miscarriage is a priority for you and you understand the trade-off in embryos available.

It is less likely to help if you expect only one or two blastocysts, are using donor eggs, or are being offered it because of the male partner’s age or sperm quality alone. Be cautious too if it is presented as a standard part of every cycle.

Either way, the right question is not “is PGT-A good?” but “what would I do differently depending on the result, and is that worth the trade-offs for me?” For the cost side, see our guide to PGT-A cost and quote questions.

Questions worth taking to the consultation

  • Why are you recommending PGT-A for me, and what evidence supports it in my situation?
  • How many blastocysts do you expect me to have to test?
  • How does your genetics lab report mosaic results, and would you transfer a mosaic embryo?
  • What happens to embryos reported as abnormal?
  • What would my plan and cost look like without PGT-A?
  • How does testing change the number and timing of my trips?

Already have a fertility treatment quote?

Compare the scope before comparing the sticker price. If you are gathering written estimates, keep the medication, laboratory, freezing, transfer and follow-up lines separate.

Compare a medical quoteExplore Colombia medical care

Considering fertility care in Medellín?

Use the private planning request to describe what you are comparing, your approximate timing and travel readiness. Do not upload medical records; a provider can move clinical information into its secure intake.

Request a fertility introductionCompare written quotes

Frequently asked questions

Does PGT-A increase my chance of having a baby?

For most IVF patients, current evidence says no. ASRM’s 2024 opinion says the value of PGT-A as a screening test for everyone having IVF has not been shown, and the HFEA rates it red for improving the chance of a baby for most patients. It may play a role for some older patients with good ovarian reserve, but that evidence is limited.

Can PGT-A reduce the chance of miscarriage?

The HFEA rates PGT-A green for reducing miscarriage for most fertility patients. For older women and people with a history of miscarriage, it rates the evidence grey, meaning it is unclear.

What is a mosaic embryo result?

A mosaic result means the test found a mix of cells with normal and abnormal chromosome counts in the biopsy. ASRM notes that mosaic embryos may implant at lower rates but can lead to apparently healthy babies, and that how labs report mosaicism varies. Ask the clinic how it reports mosaic results and whether it would transfer such an embryo.

Should I use PGT-A with donor eggs?

ASRM’s 2024 opinion says the overall evidence argues against routine PGT-A in donor-egg cycles. If a clinic recommends it, ask what specific reason applies to you.

Does PGT-A mean I need a second trip to Medellín?

Often, yes. Biopsied embryos are usually frozen while the results come back, so the transfer becomes a frozen transfer at a later date. Ask the clinic how long results take and whether you can prepare for the frozen transfer at home.

Medical disclaimer: MedellinIVF.co is an independent educational and lead-navigation site, not a fertility clinic. Nothing on this page is diagnosis, treatment advice or a guarantee of outcome. Prices and policies change. Verify current information directly with the treating clinic and appropriate Colombian registries.

Continue researching:MedellinIVF.coColombianIVF.comColombiaMedical.coGetMedicalQuotes.com